NanoVibronix renews PainShield distribution deal with Ultra Pain; secures $12M minimum purchase commitment

ENvue Medical, Inc.

Renewed exclusive distribution agreement with Ultra Pain Products for PainShield for five years.
Minimum purchase commitment valued at $12 million over the term of the agreement.
CEO Brian Murphy highlighted UPPI's growth and transition into manufacturing as key factors.
PainShield is a non-opioid portable ultrasound device for pain management and injury recovery.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.